MicroMatrix® Flex in Tunneling Wounds

Eligibility Criteria

• 1. Patient is ≥ 22 years at the time of consent
• 2. Patient with a diagnosis of pressure injury, venous ulcer, diabetic ulcer, necrotizing soft tissue infection associated wound, dehiscing and/or draining wounds associated with open abdominal procedures, or any indication per the Instructions For Use
• 3. Patient is willing and able to adhere to protocol requirements and comply with the study follow-up regimen
• 4. Patient has reviewed the IRB/IEC-approved consent form, has been properly consented per the protocol and has documented their consent to participate in the study by signing the IRB/IEC-approved consent form
• 1. Burn as etiology of wound
• 2. Unmanaged infection and/or osteomyelitis as determined pre-operatively
• 3. Known allergy, hypersensitivity, or objection to porcine materials, due to religion, culture, or other
• 4. Patient report of concurrent participation in another clinical trial that would interfere with this study
• 5. Any condition, concomitant medication, or concomitant treatment that, in the opinion of the investigator, would preclude the use of the study device or preclude the patient from completing the follow-up requirements